Vineet Laboratories Limited
Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl… Read more
Market Cap & Net Worth: Vineet Laboratories Limited (VINEETLAB)
Vineet Laboratories Limited (NSE:VINEETLAB) has a market capitalization of $6.43 Million (₹557.17 Million) as of March 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #33917 globally and #1899 in its home market, demonstrating a -7.96% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vineet Laboratories Limited's stock price ₹29.01 by its total outstanding shares 19206266 (19.21 Million).
Vineet Laboratories Limited Market Cap History: 2021 to 2026
Vineet Laboratories Limited's market capitalization history from 2021 to 2026. Data shows change from $17.90 Million to $6.43 Million (-9.01% CAGR).
Vineet Laboratories Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vineet Laboratories Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Vineet Laboratories Limited's market cap is 0.01 times its annual revenue
8.83x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $17.90 Million | $2.43 Billion | $17.80 Million | 0.01x | 1.01x |
| 2022 | $14.03 Million | $1.91 Billion | $66.39 Million | 0.01x | 0.21x |
| 2023 | $18.11 Million | $2.12 Billion | $12.53 Million | 0.01x | 1.45x |
| 2024 | $13.12 Million | $1.51 Billion | $10.27 Million | 0.01x | 1.28x |
| 2025 | $8.16 Million | $749.95 Million | -$201.91 Million | 0.01x | N/A |
Competitor Companies of VINEETLAB by Market Capitalization
Companies near Vineet Laboratories Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Vineet Laboratories Limited by market ranking:
- Linde PLC (XETRA:LIN): Ranked #84 globally with a market cap of $187.60 Billion USD ( €182.76 Billion EUR).
- BASF SE NA O.N. (OTCQX:BFFAF): Ranked #461 globally with a market cap of $47.09 Billion USD.
- Shin-Etsu Chemical Co. Ltd (PINK:SHECF): Ranked #470 globally with a market cap of $46.17 Billion USD.
- A. Schulman Inc (PINK:SLMNP): Ranked #826 globally with a market cap of $23.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Linde PLC | XETRA:LIN | $187.60 Billion | €429.40 |
| #461 | BASF SE NA O.N. | OTCQX:BFFAF | $47.09 Billion | $53.46 |
| #470 | Shin-Etsu Chemical Co. Ltd | PINK:SHECF | $46.17 Billion | $24.66 |
| #826 | A. Schulman Inc | PINK:SLMNP | $23.93 Billion | $901.00 |
Vineet Laboratories Limited Historical Marketcap From 2021 to 2026
Between 2021 and today, Vineet Laboratories Limited's market cap moved from $17.90 Million to $ 6.43 Million, with a yearly change of -9.01%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹6.43 Million | -21.13% |
| 2025 | ₹8.16 Million | -37.81% |
| 2024 | ₹13.12 Million | -27.57% |
| 2023 | ₹18.11 Million | +29.09% |
| 2022 | ₹14.03 Million | -21.64% |
| 2021 | ₹17.90 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Vineet Laboratories Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.43 Million USD |
| MoneyControl | $6.43 Million USD |
| MarketWatch | $6.43 Million USD |
| marketcap.company | $6.43 Million USD |
| Reuters | $6.43 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.